Company History

  • June-July 2014

    China Biologic sold 920,000 shares of common stock from its treasury stock in a follow-on offering, and raised net proceeds of approximately $33.2 million.
  • Mar 2014

    Guizhou Taibang received the renewed Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its updated plasma production facility.
  • January 2014

    Guizhou Taibang received the renewed Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its updated placenta polypeptide production facility.
  • January 2014

    China Biologic repurchased 2,500,000 shares of common stock from one of its individual shareholders for a consideration of $70,000,000.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:6 [2] [3] [4] [5] [6] [7] [8] [9] [10] ...
© 2018 China Biologic Products Holdings, Inc. All Rights Reserved.